SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page2223242526272829Next Page
2026-06-03CMMB3Form 3 Filing for Gwen Melincoff at Chemomab Therapeutics Ltd.MEDIUM
This filing reports a Form 3, which indicates initial beneficial ownership, for Gwen Melincoff, a director at Chemomab Therapeutics Ltd. (CMMB). The report covers the period ending June 1, 2026. Melincoff was granted a stock option to buy American Depositary Shares (ADS) with an exercise price of $1.86 per share. The o...
Nano CapBiotechnology
Previous Page2223242526272829Next Page